Cyclic AMP-binding proteins and protein kinase during regression of Walker 256 mammary carcinoma.
D000818:Animals; D003994:Bucladesine / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism; D002499:Centrifugation, Density Gradient; D003593:Cytoplasm / Q000378:metabolism; D004351:Drug Resistance; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D006656:Protamine Kinase / Q000378:metabolism; D047428:Protein Kinase Inhibitors; D011494:Protein Kinases / Q000378:metabolism*; D051381:Rats; D011953:Receptors, Cyclic AMP / Q000378:metabolism*; D013329:Structure-Activity Relationship
D047428:Protein Kinase Inhibitors; D011953:Receptors, Cyclic AMP; D003994:Bucladesine; D011494:Protein Kinases; D006656:Protamine Kinase